Poxel Cash Flow | StatInvestor

Health Care & Life Sciences » Biotechnology | Poxel

Poxel S.A. | Cash Flow

No data

View Profile

Address	259/261, avenue Jean Jaurès Lyon Rhone-Alpes 69007 France
Employees	-
Website	http://www.poxel.com
Updated	07/08/2019
Poxel SA is a pharmaceutical company, which engages in development of molecules for the potential treatment of type 2 diabetes. Its products include Imeglimin-US/EU, Imeglimin-Japan/Asia, and PXL770. The company was founded by Sébastien Bolze, Sophie Hallakou-Bozec, Pascale Fouqueray-Grellier, Pascale Malgouyres and Thomas Kuhn on March 6, 2009 and is headquartered in Lyon, France.